KR960006393B1 - 리파마이신 유도체 염 - Google Patents

리파마이신 유도체 염 Download PDF

Info

Publication number
KR960006393B1
KR960006393B1 KR1019880000536A KR880000536A KR960006393B1 KR 960006393 B1 KR960006393 B1 KR 960006393B1 KR 1019880000536 A KR1019880000536 A KR 1019880000536A KR 880000536 A KR880000536 A KR 880000536A KR 960006393 B1 KR960006393 B1 KR 960006393B1
Authority
KR
South Korea
Prior art keywords
rifamycin
salts
formula
salt
organic base
Prior art date
Application number
KR1019880000536A
Other languages
English (en)
Korean (ko)
Other versions
KR880009026A (ko
Inventor
브루제스 티베리오
세드로 아만도
한스 반 덴 호이벨 홀저
Original Assignee
스파 소시에타 프로도피 안티비오티시 에스.피.에이
기우세페 기엘메티
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 스파 소시에타 프로도피 안티비오티시 에스.피.에이, 기우세페 기엘메티 filed Critical 스파 소시에타 프로도피 안티비오티시 에스.피.에이
Publication of KR880009026A publication Critical patent/KR880009026A/ko
Application granted granted Critical
Publication of KR960006393B1 publication Critical patent/KR960006393B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019880000536A 1987-01-26 1988-01-25 리파마이신 유도체 염 KR960006393B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT19162/87A IT1202424B (it) 1987-01-26 1987-01-26 Sali di un derivato rifamicinico
IT19162A/87 1987-01-26

Publications (2)

Publication Number Publication Date
KR880009026A KR880009026A (ko) 1988-09-13
KR960006393B1 true KR960006393B1 (ko) 1996-05-15

Family

ID=11155406

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880000536A KR960006393B1 (ko) 1987-01-26 1988-01-25 리파마이신 유도체 염

Country Status (7)

Country Link
KR (1) KR960006393B1 (zh)
CN (1) CN1015368B (zh)
ES (1) ES2006280A6 (zh)
GB (1) GB2200353B (zh)
IN (1) IN165924B (zh)
IT (1) IT1202424B (zh)
PT (1) PT86621B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0447813A1 (en) * 1990-02-28 1991-09-25 GRUPPO LEPETIT S.p.A. Water soluble salts of purpuromycin and pharmaceutical formulations thereof
BG64021B1 (bg) * 1998-11-04 2003-10-31 КОНСТАНТИНОВА Румяна Натриева сол на 3-(4-цинамил-1-пиперазинил)-иминометил рифамицин и метод за получаването й
HUE054955T2 (hu) * 2012-08-13 2021-10-28 Adipharm Ead 3-Formilrifamicin S 3-(4-cinnamil-L-piperazinil)-amino származékait tartalmazó gyógyszerészeti készítmények

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1201963B (it) * 1983-03-24 1989-02-02 Prodotti Antibiotici Spa Derivati delle rifamicine e procedimento per la loro preparazione

Also Published As

Publication number Publication date
IN165924B (zh) 1990-02-10
CN88100328A (zh) 1988-09-28
KR880009026A (ko) 1988-09-13
PT86621A (pt) 1988-02-01
GB8801577D0 (en) 1988-02-24
CN1015368B (zh) 1992-02-05
GB2200353A (en) 1988-08-03
PT86621B (pt) 1991-12-31
IT8719162A0 (it) 1987-01-26
IT1202424B (it) 1989-02-09
ES2006280A6 (es) 1989-04-16
GB2200353B (en) 1990-11-28

Similar Documents

Publication Publication Date Title
SU1598873A3 (ru) Способ получени производных хинолина или их фармацевтически приемлемых сложных эфиров или фармацевтически приемлемых аддитивных солей кислоты
SU1153830A3 (ru) Способ получени сложных эфиров @ -аминопенициллинов или их кислотно-аддитивных солей
JP2731636B2 (ja) 抗潰瘍剤、抗生物質の錯体又はキレート及びその製造方法
KR960006393B1 (ko) 리파마이신 유도체 염
JPH0633310B2 (ja) 11−アザ−10−デオキソ−10−ジヒドロエリスロマイシンa又はそのn−メチル誘導体の金属錯塩及びそれらの製造法
US3769298A (en) Substituted aminomethylcarbazoles
EP0028698A1 (en) Quinoline compounds, process for their preparation, and pharmaceutical compositions
US9981985B2 (en) Pharmaceutical formulations containing 3-(4-cinnamyl-l-piperazinyl) amino derivatives of 3-formylrifamycin SV and 3-formylrifamycin S and a process of their preparation
JPH0631301B2 (ja) 抗細菌性9−デオキソ―9a―アリルおよびプロパルギル―9a―アザ―9a―ホモエリスロマイシンA誘導体
US4393053A (en) Thiolic derivatives or erythromycin having therapeutic activity and pharmaceutical compositions containing them
JPS60126284A (ja) ピリドンカルボン酸誘導体およびその塩
JPH0128744B2 (zh)
US4478843A (en) 5-Phenyltetrazoles and their use as salidiuretics
US6476036B1 (en) Sodium salt of 3-(4-cinnamyl-1-piperazinyl)-imino-methyl rifamycin SV
JP2821912B2 (ja) 動物用抗菌剤
US3903086A (en) Nitrofuryl-triazolo{8 4,3b{9 pyridazine-amide compounds and bacteriostatic compositions
KR840000522B1 (ko) 퀴놀린 화합물의 제조방법
US3347862A (en) Piperazine 2, 6-diiodo-4-nitrophenyl phosphate
US3660384A (en) 5-(2-(5-nitro-2-furyl)vinyl)picolinohydroxamic acid
US4034096A (en) Nitrogen containing derivatives of cyclopenteno-quinolone compounds and bacteriostatic compositions
KR100226273B1 (ko) 신규 세팔로스포린계 수용성 유도체 및 그의 제조방법
JPS59513B2 (ja) N−置換サイクロセリンの製造法
KR790001501B1 (ko) 미데카마이신 유도체 제법
JPS6243987B2 (zh)
RU1037644C (ru) Ди-N-окись 6-(7)-фтор-2-оксиметил-3-карбоксамидохиноксалина, обладающа антибактериальной активностью

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20030512

Year of fee payment: 8

LAPS Lapse due to unpaid annual fee